Good preso.
GLP1s should have no impact on SOM, as they target the mild OSAs. Anything they lose will be made up by people able to come off CPAP and get away with an oral appliance. Compliance and comfort with oral devices I expect is better than CPAP.
- Forums
- ASX - By Stock
- SOM
- Ann: Wilson's conference- presentation
Ann: Wilson's conference- presentation, page-2
Featured News
Add SOM (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.86M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 124380 | 25.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.5¢ | 7500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 124380 | 0.250 |
1 | 200000 | 0.245 |
6 | 182574 | 0.240 |
1 | 15000 | 0.235 |
1 | 30000 | 0.230 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 7500 | 1 |
0.275 | 31359 | 2 |
0.280 | 85045 | 1 |
0.290 | 26000 | 1 |
0.300 | 8032 | 3 |
Last trade - 16.12pm 21/06/2024 (20 minute delay) ? |
Featured News
SOM (ASX) Chart |
Day chart unavailable
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online